BELINDA TUZOLANA: Open Payments
NPI 1427728666 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 34 payments from 12 companies in 2025. Trend: 2023 $543 · 2024 $1,316 · 2025 $735
Food & beverage: $694Education: $40
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $133 |
| Calliditas Therapeutics US Inc. | 5 | $120 |
| Amgen Inc. | 5 | $102 |
| Lilly USA, LLC | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 2 | $67 |
| Novo Nordisk Inc | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: Kerendia, TARPEYO, JARDIANCE, Vanrafia, TAVNEOS, Ozempic, PREVYMIS, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
